Citation Impact
Citing Papers
Myocardial infarction redefined—A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction
2000 Standout
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2007
Minor myocardial injury after elective uncomplicated successful PTCA with or without stenting: Detection by cardiac troponins
2001
Mechanisms of Thrombus Formation
2008 Standout
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Universal Definition of Myocardial Infarction
2007 Standout
Cardiac Troponin T in Patients With Clinically Suspected Myocarditis
1997
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Tachykinins and calcitonin gene-related peptide (CGRP) as co-transmitters released from peripheral endings of sensory nerves
1995
Renal vascular effects of the selective endothelin receptor antagonists in anaesthetized rats
1997 StandoutNobel
Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens
2006 Standout
Prospects for Cardiovascular Research
2001 StandoutNobel
Antithrombotic Therapy for VTE Disease
2016 Standout
Exercise Standards for Testing and Training
2013 Standout
Biomarker Approach to the Detection and Cardioprotective Strategies During Anthracycline Chemotherapy
2011
A novel sandwich immunosensing method for measuring cardiac troponin I in sera
2003
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
ACC/AHA 2002 Guideline Update for Exercise Testing: Summary Article
2002 Standout
Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper
2009 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Implementation of serum cardiac troponin I as marker for detection of acute myocardial infarction
1999
Cardiac-Specific Troponin I Levels to Predict the Risk of Mortality in Patients with Acute Coronary Syndromes
1996
Use of Biochemical Markers of Infarction for Diagnosing Perioperative Myocardial Infarction and Early Graft Occlusion After Coronary Artery Bypass Surgery
2002
Atrial Natriuretic Factor: Implications for Cardiac Pacing and Electrophysiology
1994
Executive Summary
2012 Standout
Cardiac troponin T, creatine kinase, and its isoform release after successful percutaneous transluminal coronary angioplasty with or without stenting
1998
Myocardial Markers of Injury:Evolution and Insights
1996
Congestive heart failure in patients treated with doxorubicin
2003 Standout
Cardiac troponin I as a predictor of major cardiac events in emergency department patients with acute chest pain
1998
Myonecrosis After Revascularization Procedures
1998
Peri-procedural myocardial injury: 2005 update
2005
Update on Myocarditis
2012 Standout
Myocarditis
2000 Standout
Antithrombotic Therapy in Neonates and Children
2008
Third Universal Definition of Myocardial Infarction
2012 Standout
Antithrombotic Therapy in Neonates and Children
2012
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
2003 Standout
Tendon Injury and Tendinopathy
2005 Standout
The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI
2000 Standout
Cardiac Troponin I and Troponin T: Recent Players in the Field of Myocardial Markers
1999
Comparison of cardiac troponin T and I and CK-MB for the detection of minor myocardial damage during interventional cardiac procedures
2000
Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice
2003 StandoutNobel
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Sensitive and real-time fiber-optic-based surface plasmon resonance sensors for myoglobin and cardiac troponin I
2004
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Endothelin and endothelin antagonism: Roles in cardiovascular health and disease
1995
Cardiac troponin I: Its contribution to the diagnosis of perioperative myocardial infarction and various complications of cardiac surgery
2001
Myocarditis
2009 Standout
Costs of an Emergency Department—Based Accelerated Diagnostic Protocol vs Hospitalization in Patients With Chest Pain
1997
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary Syndromes
1998 Standout
Myocarditis
2006 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Adrenomedullin gene expression differences in mice do not affect blood pressure but modulate hypertension-induced pathology in males
2007 StandoutNobel
Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience
2002 Standout
Hemostatic Activation and Outcome After Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke
2006
Atrial Fibrillation Begets Atrial Fibrillation
1995 Standout
Predictive Value of Cardiac Troponin T in Pediatric Patients at Risk for Myocardial Injury
1997
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Significance of Mild Transient Release of Creatine Kinase–MB Fraction After Percutaneous Coronary Interventions
1996
Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary Revascularization
1997 Standout
Diagnosis and Management of Cerebral Venous Thrombosis
2011 Standout
National Academy of Clinical Biochemistry Standards of Laboratory Practice: Recommendations for the Use of Cardiac Markers in Coronary Artery Diseases
1999
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Clinical End Points in Coronary Stent Trials
2007 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Surface Plasmon Resonance Sensors for Detection of Chemical and Biological Species
2008 Standout
Vascular Actions of Calcitonin Gene-Related Peptide and Adrenomedullin
2004
What to do when you question cardiac troponin values
2017
Fourth universal definition of myocardial infarction (2018)
2018 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2011
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
The Myth of the Myocardial ‘Infarctlet’ During Percutaneous Coronary Revascularization Procedures
1996
Correlation Between Serum Levels of Cardiac Troponin-T and the Severity of the Chronic Cardiomyopathy Induced by Doxorubicin
1999
Weekend versus Weekday Admission and Mortality from Myocardial Infarction
2007 Standout
Creatine and Creatinine Metabolism
2000 Standout
Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs
2010 Standout
2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2013
Works of N Genser being referenced
Cardiac troponin I to diagnose percutaneous transluminal coronary angioplasty-related myocardial injury
1997
Side-branch occlusion during percutaneous transluminal coronary angioplasty
1992
Calcitonin gene-related peptide in patients with and without early reperfusion after acute myocardial infarction
1992
Endothelin-1 in patients with complicated and uncomplicated myocardial infarction
1992
Cardiac troponin I in the diagnosis of myocardial injury and infarction
1996
Cardiac troponin T and creatine kinase MB mass concentrations in children receiving anthracycline chemotherapy
1995
Equivalent early sensitivities of myoglobin, creatine kinase MB mass, creatine kinase isoform ratios, and cardiac troponins I and T for acute myocardial infarction
1995
[Values of atrial natriuretic peptide (ANP) and cyclic guanosine monophosphate (cGMP) in cardioversion].
1991
[Thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in 13 children: a case series].
2000
Plasma immunoreactive endothelin in the acute and subacute phases of myocardial infarction in patients undergoing fibrinolysis
1993
Rebound increase of plasminogen activator inhibitor type 1 after cessation of thrombolytic treatment for acute myocardial infarction is independent of type of plasminogen activator used
1998